Trading Halt
Released
Released
Announcement PDF
Market Announcement
19 October 2023
Microba Life Sciences Limited (ASX: MAP) – Trading Halt
Description
The securities of Microba Life Sciences Limited (‘MAP’) will be placed in trading halt at the request of MAP,
pending it releasing an announcement regarding the outcome of the institutional component of the
accelerated entitlement offer. Unless ASX decides otherwise, the securities will remain in trading halt until the
commencement of normal trading on Monday, 23 October 2023.
Issued by
Lisa Banh
Senior Adviser, Listings Compliance
19 October 2023
ASX Limited
Market Announcement 1/1
ASX Customer Service Centre 131 279 | asx.com.au
ASX Announcement
19 October 2023
Ms Lisa Banh
Adviser Listings ASX Compliance (Sydney)
20 Bridge Street
SYDNEY, NSW 2000
By email: tradinghaltssydney@asx.com.au
Request for a trading halt
Microba Life Sciences Ltd (ASX:MAP) (Microba), requests an immediate trading halt be granted by ASX Limited in respect of
its shares on Thursday, 19 October 2023.
The trading halt is requested as Microba expects to announce a proposed acquisition (Acquisition) and an accelerated nonrenounceable entitlement offer (ANREO).
In accordance with ASX Listing Rule 17.1, Microba provides the following information:
(a)
the trading halt is necessary for Microba to make an announcement to the market in relation to the Acquisition and
the results of the institutional offer component of the ANREO;
(b)
the trading halt should remain in place until the commencement of trading on Monday, 23 October 2023;
(c)
Microba is not aware of any reason why the trading halt should not be granted; and
(d)
Microba is not aware of any other information necessary to inform the market about the trading halt.
Yours sincerely
Peter Webse
Joint Company Secretary
Authorised for release by the Board.
Microba encourages all current investors to go paperless by registering their details with the designated registry service
provider, Automic Group.
Microba Life Sciences Ltd ABN 82 617 096 652
Level 10, 324 Queen Street, Brisbane QLD 4000 Australia
T: 1300 974 621 E: investor@microba.com W: microba.com
Share your feedback
Discover